Stock Analysis

Chaoju Eye Care Holdings Full Year 2022 Earnings: Revenues Disappoint

Source: Shutterstock

Chaoju Eye Care Holdings (HKG:2219) Full Year 2022 Results

Key Financial Results

  • Revenue: CN¥990.0m (flat on FY 2021).
  • Net income: CN¥187.8m (up 16% from FY 2021).
  • Profit margin: 19% (up from 16% in FY 2021).
  • EPS: CN¥0.27 (up from CN¥0.26 in FY 2021).
SEHK:2219 Earnings and Revenue Growth March 29th 2023

All figures shown in the chart above are for the trailing 12 month (TTM) period

Chaoju Eye Care Holdings Earnings Insights

Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Healthcare industry in Hong Kong.

Performance of the Hong Kong Healthcare industry.

The company's shares are up 4.5% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Chaoju Eye Care Holdings that you should be aware of before investing here.

Valuation is complex, but we're helping make it simple.

Find out whether Chaoju Eye Care Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis